• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.

作者信息

Klaschik Kristina, Hauke Jan, Neidhardt Guido, Tränkle Christian, Surowy Harald M, Heilmann-Heimbach Stefanie, Rappl Gunter, Mangold Elisabeth, Arnold Norbert, Niederacher Dieter, Sutter Christian, Burwinkel Barbara, Engel Christoph, Wappenschmidt Barbara, Meindl Alfons, Ernst Corinna, Weber-Lassalle Konstantin, Weber-Lassalle Nana, Schmidt Sandra, Borde Julika, Schmutzler Rita K, Hahnen Eric, Pohl-Rescigno Esther

机构信息

Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.

Institute of Pharmacy, Pharmacology & Toxicology, University of Bonn, Bonn, Germany.

出版信息

Int J Cancer. 2019 Apr 1;144(7):1761-1763. doi: 10.1002/ijc.32016. Epub 2019 Jan 6.

DOI:10.1002/ijc.32016
PMID:30474284
Abstract
摘要

相似文献

1
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.GPRC5A移码变体c.183del与BRCA1突变携带者患乳腺癌风险增加无关。
Int J Cancer. 2019 Apr 1;144(7):1761-1763. doi: 10.1002/ijc.32016. Epub 2019 Jan 6.
2
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.回应：GPRC5A 移码变异体 c.183del 与 BRCA1 突变携带者患乳腺癌风险增加无关。
Int J Cancer. 2019 Apr 1;144(7):1758-1760. doi: 10.1002/ijc.32013. Epub 2019 Jan 6.
3
High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.BRCA1 突变型乳腺癌患者中 GPRC5A 种系突变的高发生率。
Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27.
4
Histopathological features of breast cancer in carriers of ATM gene variants.ATM基因变异携带者乳腺癌的组织病理学特征
Histopathology. 2006 Nov;49(5):523-32. doi: 10.1111/j.1365-2559.2006.02538.x.
5
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.正常乳腺中BRCA1或BRCA2的种系突变与雌激素反应蛋白表达改变及孕激素受体A占优势有关。
Genes Chromosomes Cancer. 2004 Mar;39(3):236-48. doi: 10.1002/gcc.10321.
6
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.在对携带BRCA1突变者进行前瞻性长期随访期间，预防性卵巢切除术可降低乳腺癌的发病风险。
J Clin Oncol. 2005 Dec 1;23(34):8629-35. doi: 10.1200/JCO.2005.02.9199.
7
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.BRCA1和BRCA2种系突变携带者的正常乳腺组织及浸润性乳腺癌中的miRNA表达模式。
Oncotarget. 2015 Oct 13;6(31):32115-37. doi: 10.18632/oncotarget.5617.
8
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.BRCA1和BRCA2对早发性乳腺癌的不同贡献。
N Engl J Med. 1997 May 15;336(20):1416-21. doi: 10.1056/NEJM199705153362003.
9
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.常见BRCA2变异与BRCA1突变携带者患乳腺癌和卵巢癌风险的改变
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):265-7.
10
Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.种系BRCA1和BRCA2序列改变对印度北部乳腺癌的影响。
BMC Med Genet. 2006 Oct 4;7:75. doi: 10.1186/1471-2350-7-75.

引用本文的文献

1
Breed-Associated Differences in Differential Gene Expression Following Immunotherapy-Based Treatment of Canine High-Grade Glioma.基于免疫疗法治疗犬高级别胶质瘤后差异基因表达的品种相关差异
Animals (Basel). 2024 Dec 26;15(1):28. doi: 10.3390/ani15010028.
2
Exploring the Prognostic Value and Immune Infiltration Patterns of GPRC5A Across Multiple Cancer Types.探索GPRC5A在多种癌症类型中的预后价值和免疫浸润模式。
J Cancer. 2024 Jul 9;15(14):4749-4758. doi: 10.7150/jca.93217. eCollection 2024.
3
miR‑342 inhibits glioma cell proliferation by targeting GPRC5A.
miR-342 通过靶向 GPRC5A 抑制神经胶质瘤细胞增殖。
Mol Med Rep. 2019 Jul;20(1):252-260. doi: 10.3892/mmr.2019.10242. Epub 2019 May 15.